Alves E, Summavielle T, Alves CJ et al (2007) Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J Neurosci 27:10203–10210

Alves E, Binienda Z, Carvalho F et al (2009a) Acetyl-l-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain. Neuroscience 158:514–523

Alves E, Summavielle T, Alves CJ et al (2009b) Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A. Addict Biol 14:185–193

Atkin TA, MacAskill AF, Brandon NJ, Kittler JT (2013) Disrupted in schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry 16:122–124

Bai F, Jones DC, Lau SS, Monks TJ (2001) Serotonergic neurotoxicity of 3,4-(±)-methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase. Chem Res Toxicol 14:863–870

Barbosa DJ, Capela JP, Oliveira JMA et al (2012) Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Br J Pharmacol 165:1017–1033

Barbosa DJ, Capela JP, Silva R et al (2014a) “Ecstasy”-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites. Arch Toxicol 88:515–531

Barbosa DJ, Capela JP, Silva R et al (2014b) The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations. Arch Toxicol 88:455–473

Busceti CL, Biagioni F, Riozzi B et al (2008) Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine (“ecstasy”). J Neurosci 28:3234–3245

Byun J, Kim BT, Kim YT, Jiao Z, Hur E, Zhou F (2012) Slit2 inactivates GSK3β to signal neurite outgrowth inhibition. PLoS One 7:e51895

Capela JP, Ruscher K, Lautenschlager M et al (2006) Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139:1069–1081

Capela JP, Macedo C, Branco PS et al (2007) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146:1743–1757

Capela JP, Carmo H, Remião F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210–271

Capela JP, da Costa Araújo S, Costa VM et al (2013) The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons. Neurotoxicology 34:254–263

Carvalho M, Remiao F, Milhazes N et al (2004) The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology 200:193–203

Cereghetti GM, Stangherlin A, de Brito OM et al (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 105:15803–15808

Creed MC, Lüscher C (2013) Drug-evoked synaptic plasticity: beyond metaplasticity. Curr Opin Neurobiol 23:553–558

Darvesh AS, Gudelsky GA (2005) Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Res 1056:168–175

de Barreda EG, Pérez M, Ramos PG et al (2010) Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits. Neurobiol Dis 37:622–629

Deheshi S, Pasqualotto BA, Rintoul GL (2013) Mitochondrial trafficking in neuropsychiatric diseases. Neurobiol Dis 51:66–71

Detmer SA, Chan DC (2007) Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol 176:405–414

Feng J, Nestler EJ (2013) Epigenetic mechanisms of drug addiction. Curr Opin Neurobiol 23:521–528

Granado N, Ares-Santos S, Oliva I et al (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391–403

Itoh K, Nakamura K, Iijima M, Sesaki H (2013) Mitochondrial dynamics in neurodegeneration. Trends Cell Biol 23:64–71

Kageyama Y, Zhang Z, Roda R et al (2012) Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J Cell Biol 197:535–551

Kenny PJ (2011) Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 12:638–651

Kopeikina KJ, Carlson GA, Pitstick R et al (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer’s disease grain. Am J Pathol 179:2071–2082

Lee S, Sterky FH, Mourier A et al (2012) Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum Mol Genet 21:4827–4835

Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119:873–887

Llorens-Martín M, López-Doménech G, Soriano E, Avila J (2011) GSK3β is involved in the relief of mitochondria pausing in a tau-dependent manner. PLoS One 6:e27686

López-Doménech G, Serrat R, Mirra S et al (2012) The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2. Nat Commun 3:814

Lüscher C (2013) Cocaine-evoked synaptic plasticity of excitatory transmission in the ventral tegmental area. Cold Spring Harb Perspect Med 3:a012013

Lüscher C, Malenka RC (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69:650–663

MacAskill AF, Kittler JT (2010) Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20:102–112

Macaskill AF, Rinholm JE, Twelvetrees AE et al (2009) Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 61:541–555

MacAskill AF, Atkin TA, Kittler JT (2010) Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci 32:231–240

Miller KE, Sheetz MP (2004) Axonal mitochondrial transport and potential are correlated. J Cell Sci 117:2791–2804

Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH (2010) Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 30:4232–4240

Misko AL, Sasaki Y, Tuck E, Milbrandt J, Baloh RH (2012) Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration. J Neurosci 32:4145–4155

Morel M, Authelet M, Dedecker R, Brion JP (2010) Glycogen synthase kinase-3β and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons. Neuroscience 167:1044–1056

Park H, Kam T, Kim Y et al (2012) Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Hum Mol Genet 21:2725–2737

Pathak D, Sepp KJ, Hollenbeck PJ (2010) Evidence that myosin activity opposes microtubule-based axonal transport of mitochondria. J Neurosci 30:8984–8992

Perier C, Vila M (2012) Mitochondrial biology and Parkinson’s disease. Cold Spring Harb Perspect Med 2:a009332

Puerta E, Hervias I, Goñi-Allo B et al (2010) Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity. Br J Pharmacol 160:233–245

Quinton MS, Yamamoto BK (2006) Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 8:337–347

Ricaurte GA, Yuan J, McCann UD (2000) (±)3,4-Methylenedioxymethamphetamine (‘ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5–10

Rintoul GL, Reynolds IJ (2010) Mitochondrial trafficking and morphology in neuronal injury. Biochim Biophys Acta 1802:143–150

Saxton WM, Hollenbeck PJ (2012) The axonal transport of mitochondria. J Cell Sci 125:2095–2104

Shahpasand K, Uemura I, Saito T et al (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer’s disease. J Neurosci 32:2430–2441

Shao L, Martin MV, Watson SJ et al (2008) Mitochondrial involvement in psychiatric disorders. Ann Med 40:281–295

Sheng Z, Cai Q (2012) Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13:77–93

Shutt TE, McBride HM (2013) Staying cool in difficult times: mitochondrial dynamics, quality control and the stress response. Biochim Biophys Acta 1833:417–424

Simantov R, Tauber M (1997) The abused drug MDMA (ecstasy) induces programmed death of human serotonergic cells. FASEB J 11:141–146

van Spronsen M, Mikhaylova M, Lipka J et al (2013) TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 77:485–502

Verstreken P, Ly CV, Venken KJT, Koh T, Zhou Y, Bellen HJ (2005) Synaptic mitochondria are critical for mobilization of reserve pool vesicles at drosophila neuromuscular junctions. Neuron 47:365–378

Vossel KA, Zhang K, Brodbeck J et al (2010) Tau reduction prevents Aβ-induced defects in axonal transport. Science 330:198

Wang X, Schwarz TL (2009) The mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 136:163–174

Wang DB, Garden GA, Kinoshita C et al (2013) Declines in Drp1 and Parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. J Neurosci 33:1357–1365